Inmunobiología linfocitaria
University of Oxford
Oxford, Reino UnidoPublicaciones en colaboración con investigadores/as de University of Oxford (11)
2023
-
Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19
Genome Medicine, Vol. 15, Núm. 1
2021
-
On the relevance of immunodeficiency evaluation in haematological cancer
Hematological Oncology
-
The PID Principles of Care: Where Are We Now? A Global Status Report Based on the PID Life Index
Frontiers in Immunology, Vol. 12
2019
-
Editorial: Reverse Vaccinology
Frontiers in Immunology
-
p38γ is essential for cell cycle progression and liver tumorigenesis
Nature
2018
-
Extracellular vesicle heterogeneity: Subpopulations, isolation techniques, and diverse functions in cancer progression
Frontiers in Immunology, Vol. 9, Núm. APR
-
Minimum information about T regulatory cells: A step toward reproducibility and standardization
Frontiers in Immunology, Vol. 8, Núm. JAN
2016
-
Challenges in the role of gammaglobulin replacement therapy and vaccination strategies for hematological malignancy
Frontiers in Immunology, Vol. 7, Núm. AUG
2015
-
Hurdles in therapy with regulatory T cells
Science Translational Medicine, Vol. 7, Núm. 304
2014
-
Primary immune deficiencies - principles of care
Frontiers in Immunology, Vol. 5, Núm. DEC
2012
-
Design and Evaluation of Meningococcal Vaccines through Structure-Based Modification of Host and Pathogen Molecules
PLoS Pathogens, Vol. 8, Núm. 10